Abecassis Leah, Gaffin Jonathan M, Forbes Peter W, Schenkel Sara R, McBride Sarah, DeGrazia Michele
Cardiovascular and Critical Care Services, Boston Children's Hospital, Boston, MA, USA.
Division of Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.
J Asthma. 2022 Feb;59(2):315-324. doi: 10.1080/02770903.2020.1852414. Epub 2020 Dec 2.
The Hospital Asthma Severity Score (HASS) was developed to communicate inpatient asthma severity between providers. The purpose of this prospective study was to validate the HASS against the Pediatric Respiratory Assessment Measure (PRAM) and spirometry for assessment of inpatient asthma exacerbation severity in patients 2-18 years old, at a single point-in-time.
This study was registered with clinicaltrials.gov (NCT02782065). Children admitted to a tertiary care, free-standing children's hospital were assessed for asthma severity using the HASS, PRAM, and pulmonary function by spirometry. Inter-rater agreement of HASS and PRAM scores was assessed between two blinded clinician raters. Spirometry results were obtained by a certified pulmonary laboratory technician and correlated with HASS and PRAM scores.
The sample included 58 subjects. Allowing for a one-point difference in continuous HASS and PRAM scores, inter-rater agreement was 79% for the HASS and 60% for the PRAM. When the scores were categorized as mild, moderate, and severe, inter-rater agreement was 62% for the HASS and 93% for the PRAM ( < .0001). Additionally, intra-rater agreement between HASS and PRAM severity categories was 71% for Rater 1 and 64% for Rater 2. A weak correlation was noted between both the HASS and FEV (r = -0.31; = 0.11), and PRAM and FEV (r = -0.30; = 0.11) for the 29 subjects with acceptable spirometry results.
The HASS and PRAM have acceptable inter-rater and intra-rater agreement. These results support validation of the HASS for managing hospitalized patients during asthma exacerbations.
医院哮喘严重程度评分(HASS)旨在供医护人员交流住院患者的哮喘严重程度。这项前瞻性研究的目的是,在单一时间点,针对2至18岁住院哮喘加重患者,对照儿科呼吸评估量表(PRAM)和肺活量测定法,验证HASS。
本研究已在clinicaltrials.gov注册(NCT02782065)。对一家独立的三级护理儿童医院收治的儿童,使用HASS、PRAM和肺活量测定法评估哮喘严重程度。两名盲法临床评估者对HASS和PRAM评分的评估者间一致性进行了评估。肺活量测定结果由一名经过认证的肺功能实验室技术人员获取,并与HASS和PRAM评分相关联。
样本包括58名受试者。若HASS和PRAM连续评分允许有1分差异,HASS的评估者间一致性为79%,PRAM为60%。当将评分分为轻度、中度和重度时,HASS的评估者间一致性为62%,PRAM为93%(<0.0001)。此外,评估者1对HASS和PRAM严重程度分类的评估者内一致性为71%,评估者2为64%。对于29名肺活量测定结果合格的受试者,HASS与第一秒用力呼气容积(FEV)(r = -0.31;P = 0.11)以及PRAM与FEV(r = -0.30;P = 0.11)之间均存在弱相关性。
HASS和PRAM具有可接受的评估者间和评估者内一致性。这些结果支持在哮喘加重期间对住院患者管理中使用HASS的有效性验证。